Home Healthcare

Search documents
Addus HomeCare (ADUS) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
ZACKS· 2025-08-05 00:01
Core Insights - Addus HomeCare reported revenue of $349.44 million for the quarter ended June 2025, reflecting a year-over-year increase of 21.8% and a surprise of +0.4% over the Zacks Consensus Estimate of $348.04 million [1] - The company's EPS for the quarter was $1.49, up from $1.35 in the same quarter last year, resulting in an EPS surprise of +2.76% compared to the consensus estimate of $1.45 [1] Revenue Breakdown - Personal Care revenue reached $269.18 million, exceeding the two-analyst average estimate of $265.88 million, with a year-over-year increase of +26.5% [4] - Home Health revenue was reported at $18.05 million, slightly below the two-analyst average estimate of $18.26 million, showing a year-over-year change of -0.2% [4] - Hospice revenue amounted to $62.21 million, surpassing the average estimate of $61.32 million from two analysts, with a year-over-year increase of +11% [4] Stock Performance - Over the past month, Addus HomeCare shares have returned -6.2%, contrasting with the Zacks S&P 500 composite's +0.6% change [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating potential performance in line with the broader market in the near term [3]
Here's What Key Metrics Tell Us About Amedisys (AMED) Q2 Earnings
ZACKS· 2025-07-30 00:31
Group 1 - Amedisys reported $621.86 million in revenue for the quarter ended June 2025, a year-over-year increase of 5.2% [1] - The EPS for the same period was $1.54, compared to $1.32 a year ago, representing a surprise of +10.79% over the consensus estimate of $1.39 [1] - The reported revenue exceeded the Zacks Consensus Estimate of $609.65 million by +2% [1] Group 2 - Key metrics for Amedisys include Net Service Revenue for High Acuity Care at $10.7 million, a +9.2% change year-over-year [4] - Net Service Revenue for Hospice was reported at $215 million, reflecting a +5.4% year-over-year change [4] - Net Service Revenue for Home Health was $396.2 million, representing a +5% increase compared to the previous year [4] Group 3 - Amedisys shares have returned -1.5% over the past month, underperforming the Zacks S&P 500 composite's +3.6% change [3] - The stock currently holds a Zacks Rank 4 (Sell), indicating potential underperformance in the near term [3]
BrightSpring Health Services, Inc. to Announce Second Quarter 2025 Financial Results on August 1, 2025
Globenewswire· 2025-07-08 20:05
Company Overview - BrightSpring Health Services, Inc. provides home- and community-based pharmacy and provider health solutions for complex populations requiring specialized and chronic care [3] - The company operates across all 50 states, serving over 450,000 customers, clients, and patients daily [3] - BrightSpring has shown strong quality metrics across its service lines, improving the quality of life for high-need individuals while reducing overall healthcare costs [3] Financial Results Announcement - BrightSpring plans to release its second quarter 2025 financial results on August 1, 2025, prior to its earnings conference call [1] - The earnings conference call is scheduled for 8:30 a.m. ET on the same day [1] Conference Call Participation - Interested participants must register before the conference call starts at 8:30 a.m. ET [2] - A live and archived webcast of the call will be available on the company's investor relations website [2]
Extendicare Acquires Closing the Gap Healthcare Group
Globenewswire· 2025-07-02 12:07
Core Viewpoint - Extendicare Inc. has successfully acquired Closing the Gap Healthcare Group Inc. for $75.5 million, enhancing its home healthcare services and capabilities in rehabilitation [1][2][3] Group 1: Acquisition Details - The acquisition of Closing the Gap was completed on July 1, 2025, on a debt-free, cash-free basis, with an initial cash consideration of $75.5 million, subject to adjustments [2] - An additional earnout of $3.5 to $5.5 million is anticipated based on new business revenue generated in the twelve months following the acquisition [2] - The purchase price was funded through cash on hand and existing senior secured credit facilities [2] Group 2: Financial Strategy - Extendicare announced a $100 million increase to its Senior Secured Credit Facility, raising the total to $375 million, which includes $55 million in a delayed draw term loan and $45 million in a revolving credit facility [3] - The company plans to utilize the additional $55 million in the third quarter for strategic acquisitions and organic growth [4] Group 3: Company Overview - Extendicare is a leading provider of care and services for seniors in Canada, operating 99 long-term care homes and delivering approximately 11.2 million hours of home health care services annually [6] - The company employs around 27,500 qualified team members dedicated to providing high-quality care [6]
Option Care Health to Announce Second Quarter 2025 Financial Results and Host Conference Call
Globenewswire· 2025-06-25 20:05
Core Viewpoint - Option Care Health Inc. is set to release its second quarter results for the period ending June 30, 2025, on July 30, 2025, before market opening, followed by a conference call to discuss the results [1]. Group 1: Company Overview - Option Care Health is the largest independent provider of home and alternate site infusion services in the United States [3]. - The company employs over 8,000 team members, including more than 5,000 clinicians, dedicated to improving care standards for patients with acute and chronic conditions across all 50 states [3]. - Option Care Health aims to enhance the infusion care experience through its clinical leadership, expertise, and national scale [3]. Group 2: Conference Call Details - Participants can pre-register for the conference call through a provided link and access it via a live audio webcast available on the company's investor relations website [2]. - A replay of the conference call will be available shortly after its completion and will remain accessible for approximately 90 days [2].
Residential Home Health and Hospice Receives 2025 Top Workplaces Honors
Prnewswire· 2025-06-23 12:40
Core Insights - Residential Home Health and Hospice has been awarded the Top Workplaces 2025 honors by the St. Louis Post-Dispatch, marking the fifth consecutive year of receiving this recognition in the St. Louis market [1][4]. Company Overview - Graham Healthcare Group (GHG) is a subsidiary of Graham Holdings Company, employing over 3,000 professionals and serving 19,000 patients daily [6]. - Residential Home Health and Hospice provides skilled home health, palliative, and hospice care across multiple states including Florida, Illinois, Kansas, Michigan, Missouri, Ohio, and Pennsylvania [7]. Award Significance - The Top Workplaces Award is based solely on employee feedback collected through a third-party survey by Energage LLC, focusing on employee satisfaction and engagement [2][3]. - The award reflects the company's commitment to creating a supportive work environment, which in turn empowers employees to deliver exceptional care to patients [4].
Can BrightSpring's Q1 Strength Carry Through 2025 Headwinds?
ZACKS· 2025-06-20 13:46
Core Insights - BrightSpring Health Services (BTSG) reported strong financial results for Q1 2025, with total revenues increasing by 26% year over year to $2.9 billion and adjusted EBITDA rising by 28% to $131 million, despite facing operational and macroeconomic challenges [3][8] - The company raised its full-year guidance, expecting total revenues between $12 billion and $12.5 billion, which represents a year-over-year growth of 19.1% to 24.1%, and adjusted EBITDA guidance increased to $570 million to $585 million, marking a growth of 23.9% to 27.2% [4][8] Financial Performance - Total revenues for Q1 2025 were $2.9 billion, with Pharmacy Solutions and Provider Services segments growing by 28% and 12% respectively [3][8] - Adjusted EBITDA for the same period was $131 million, supported by operational efficiency initiatives and volume leverage [3][8] Operational Challenges - The company faced a negative impact of $3.7 million on EBITDA due to fewer business days in Q1 2025 compared to Q1 2024 [2] - 10% of the company's revenues are derived from Medicaid, which poses reimbursement risks due to potential federal or state-level cuts [2] - The gross margin was modestly impacted by a revenue mix shift towards the lower-margin specialty pharmacy segment [2] Market Position and Valuation - BrightSpring's shares have gained 114.8% over the past year, significantly outperforming the industry, which saw a decline of 16.2% [7] - The company currently trades at a 12-month forward price-to-earnings ratio of 20.36, compared to the industry's 14.25 [9] Peer Comparison - Option Care Health (OPCH) and Amedisys (AMED) also reported strong financial performances in Q1 2025, with OPCH seeing revenue and margin growth driven by infusion therapy demand, and AMED experiencing consistent growth in hospice and home health services [5][6]
BrightSpring's Home Health Arm Soars: What's Powering Growth?
ZACKS· 2025-06-11 14:56
Core Insights - BrightSpring Health Services, Inc. (BTSG) is experiencing significant growth in its Home Health Care segment, driven by the expanding global home healthcare market, which is projected to grow at a CAGR of 10.21% from 2025 to 2030 [1] Company Performance - The Home Health Care segment generated $178 million in sales in Q1 2025, reflecting a 21% year-over-year increase, supported by strong operational execution and expanding Medicare Advantage contracts [2][8] - The average daily census across home health and hospice increased to over 30,000, a 12% rise from the previous year, indicating robust demand for services [3] - Approximately 90% patient satisfaction was reported, with over 80% of branches rated 4 stars or higher, and a declining 60-day hospitalization rate [2][3] Strategic Initiatives - BrightSpring is advancing its Homebase Primary Care model to provide physician-led services in cost-effective, in-home settings, and is targeting scalable growth to over 100,000 patients through value-based models like ACOs and SNPs [3] Competitive Landscape - Cardinal Health's at-Home Solutions is expanding its reach in the home healthcare market, serving over 5 million patients in fiscal 2024 and investing in automated distribution centers to enhance capabilities [4] - Addus HomeCare Corporation's home healthcare segment is experiencing modest growth, focusing on selective M&A and leveraging technology for operational synergies [5] Market Valuation - BTSG shares have increased by 98.8% over the past year, significantly outperforming the industry, which saw an 18.9% decline, while the S&P 500 composite grew by 11.8% [6] - The company trades at a forward price-to-earnings ratio of 20.32, above the industry average of 14.25 [9] Earnings Estimates - The Zacks Consensus Estimate for BTSG's earnings has been rising over the past 60 days, with current estimates for Q2 2025 at $0.22 and for the current year at $1.02 [10][11]
Viemed Healthcare Announces Share Repurchase Program
Globenewswire· 2025-06-09 12:00
Core Viewpoint - Viemed Healthcare, Inc. has announced a share repurchase program, allowing the company to buy back up to 1,976,441 common shares, which is approximately 5% of the total shares outstanding as of March 31, 2025, to enhance shareholder value [1][2]. Group 1: Share Repurchase Program - The share repurchase program is effective through June 2026 and allows for purchases through open market transactions, block purchases, or other methods compliant with securities laws [1][3]. - Daily purchases will be limited to 25% of the average daily volume for the four weeks preceding the purchase date, with the price paid being the market price at the time of purchase plus applicable brokerage fees [3][4]. - The company has previously repurchased approximately 2.6 million shares since its public listing, demonstrating a commitment to disciplined capital allocation [4]. Group 2: Financial Position and Strategy - Viemed's CEO highlighted strong first quarter 2025 results and increased guidance, indicating robust underlying business fundamentals [4]. - The company has no net debt and full access to a $55 million credit facility, providing ample liquidity for both the share repurchase program and funding growth initiatives [4]. - The company is also in the process of acquiring Lehan's Medical, expected to close in the third quarter of 2025, further supporting its growth strategy [4]. Group 3: Company Overview - Viemed Healthcare is a provider of in-home clinical care for post-acute respiratory healthcare, offering services such as non-invasive ventilators, sleep therapy, and staffing [5]. - The company focuses on delivering efficient in-home treatment through clinical practitioners who provide therapy, education, and counseling using advanced technology [5].
Aveanna Healthcare Holdings Completes Acquisition of Thrive Skilled Pediatric Care
Globenewswire· 2025-06-04 11:30
Core Viewpoint - Aveanna Healthcare Holdings Inc. has completed the acquisition of Thrive Skilled Pediatric Care, enhancing its position in the pediatric home care market and expanding its service offerings into new states [1][2][3]. Company Overview - Aveanna Healthcare is a diversified home care platform providing services to medically complex, high-cost patient populations, with a presence in 36 states [7]. - The company offers a wide range of healthcare services, including nursing, rehabilitation, therapy, and case management, aimed at providing high-quality, lower-cost alternatives to prolonged hospitalization [7]. Acquisition Details - Thrive SPC is one of the largest independent providers of pediatric home care, operating 23 locations across seven states [2]. - The acquisition is expected to create significant growth opportunities for Aveanna, reinforcing its commitment to clinical excellence and compassionate care [3]. - The deal was financed through a combination of common stock and cash [3]. Strategic Implications - The integration of Thrive SPC is anticipated to enhance Aveanna's existing footprint and introduce its specialized care model into two new states [2][3]. - The acquisition aligns with Aveanna's strategic mission to lead in delivering high-quality care while providing value and clinical innovation to payors and stakeholders [3]. Advisory and Legal Support - Edge Healthcare Partners acted as the financial advisor for Aveanna, while Cantor Fitzgerald & Co. served as the financial advisor for Thrive SPC [4]. - Legal counsel for Aveanna was provided by Bass, Berry & Sims, and Ropes & Gray LLP represented Thrive SPC [4].